Clinical trial
Fetched
Post
clinicaltrials.gov
Massachusetts General Hospital
(2013).
An Open-Label Trial of Buspirone for the Treatment of Anxiety in Youth With Autism Spectrum Disorders.
ClinicalTrials.gov.
Massachusetts General Hospital.
- Publication date
-
2013
- Identifier
-
NCT01850355
- Authors
-
Massachusetts General Hospital
- Source
- ClinicalTrials.gov
- Reference type
- clinical_trial
- Publisher
- Massachusetts General Hospital
- Metadata source
- clinicaltrials.gov
Abstract
The main objective of this exploratory 8-week pilot study is to evaluate the safety and efficacy of buspirone for the treatment of anxiety in youth (ages 6-17 years) with autism spectrum disorders. The study results will be used to generate hypothesis for a larger randomized controlled clinical trials with explicit hypotheses and sufficient statistical power.